Prescription chlorpromazine tablets recalled due to manufacturing quality defect
Glenmark Pharmaceuticals is recalling chlorpromazine hydrochloride 10mg tablets nationwide due to manufacturing deviations that allowed excess N-nitroso impurity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II manufacturing defect with impurity exceeding limits. The Severe criterion requires Class II recalls with hospitalization reports, which are not mentioned. A High score reflects manufacturing quality deviation without documented adverse events.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling chlorpromazine hydrochloride tablets, USP, 10mg in 100-count bottles due to manufacturing quality issues. Approximately 3,888 units were distributed nationwide.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Testing found that N-nitroso-desmethyl chlorpromazine impurity (NNDCI) levels exceeded FDA recommended limits.
Chlorpromazine is a prescription antipsychotic medication used to treat psychiatric conditions. Affected lot numbers are 17230132 (expiration 12/2024) and 17230449 (expiration 01/2025).
Patients taking this medication should contact their healthcare provider or pharmacist. Do not discontinue medication without medical guidance. Return affected bottles to the pharmacy.
The recalled product
- Product
- CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
- Brand
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Antipsychotic
- Hazard
- n-nitroso-impurity
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 17230132
- Exp 12/2024
- 17230449
- Exp 01/2025
UPCs (4)
- 0368462862018
- 0368462864012
- 0368462863015
- 0368462861011
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORPROMAZINE HYDROCHLORIDE
- HighChlorpromazine Hydrochloride Tablets recalled for N-nitroso impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride Tablets Recalled for Elevated N-Nitroso Impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride 25 mg Tablets Recalled for Chemical Impurity
FDA (Drugs) · 2025-10-15
- HighPrescription drug recall: Chlorpromazine hydrochloride tablets due to nitrosamine impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine Hydrochloride Tablets Recalled for Manufacturing Deviation
FDA (Drugs) · 2025-10-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27